Processa Pharmaceuticals Inc. (PCSA) Misses Q3 EPS by 1c

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) reported Q3 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Processa Pharmaceuticals Inc. (PCSA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• UBS cuts KOSPI target by nearly 10% to reflect higher rates
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in